{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,23]],"date-time":"2026-04-23T03:24:36Z","timestamp":1776914676986,"version":"3.51.2"},"reference-count":26,"publisher":"The Journal of Rheumatology","issue":"Suppl 2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Rheumatol"],"published-print":{"date-parts":[[2023,11]]},"abstract":"<jats:p>Acute guttate psoriasis (AGP) is considered an uncommon variant of psoriasis (PsO), characterized as a widespread eruption of erythematous, psoriasiform papules, and plaques on the trunk, extremities, and scalp. Predisposing factors include a family history of PsO, variation in the main PsO susceptibility gene<jats:italic>HLA-Cw*0602<\/jats:italic>, and previous infection with viruses or acute \u03b2-hemolytic<jats:italic>Streptococcus<\/jats:italic>. A program focused on controversies and recent advances in understanding AGP was presented at the Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA) 2022 annual meeting. Topics included an overview of clinical presentation and natural history, predisposing genetic and environmental factors, and the recent molecular profiling that supports classification of AGP as a form of PsO. Early molecular profiling studies using proteomic signatures have suggested similarities between AGP and contact dermatitis, but recent studies using gene expression profiling and gene set enrichment scores demonstrate that AGP is more similar to chronic PsO. The expression of regulatory immune pathways seen with AGP suggests potential for early and sustained remission if the disease is suppressed by targeted treatments. Published case reports documenting clinical improvement of AGP with biologics that antagonize interleukin (IL)-12\/23, IL-23, and IL-17 support the role of the IL-23\/IL-17 axis in AGP, similar to that in PsO. Data supporting the use of antibiotics and other therapeutic agents for AGP are lacking, and randomized controlled trials are needed. Trial design for AGP is challenged by the low incidence, tendency for spontaneous remission, lack of validated end points, and the need for long-term follow up.<\/jats:p>","DOI":"10.3899\/jrheum.2023-0500","type":"journal-article","created":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T12:20:47Z","timestamp":1693570847000},"page":"4-7","source":"Crossref","is-referenced-by-count":9,"title":["Advances and Controversies in Our Understanding of Guttate and Plaque Psoriasis"],"prefix":"10.3899","volume":"50","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5464-0439","authenticated-orcid":false,"given":"Kristina Callis","family":"Duffin","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7930-9964","authenticated-orcid":false,"given":"Sam T.","family":"Hwang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3775-1778","authenticated-orcid":false,"given":"James G.","family":"Krueger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2262","published-online":{"date-parts":[[2023,9,1]]},"reference":[{"key":"2023110105251434000_50.Suppl_2.4.1","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1111\/j.1346-8138.2010.00871.x","article-title":"Clinical course of guttate psoriasis: long-term follow-up study","volume":"37","author":"Ko","year":"2010","journal-title":"J Dermatol"},{"key":"2023110105251434000_50.Suppl_2.4.2","doi-asserted-by":"publisher","DOI":"10.1067\/mjd.2001.110876"},{"key":"2023110105251434000_50.Suppl_2.4.3","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.1980.tb05690.x"},{"key":"2023110105251434000_50.Suppl_2.4.4","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2133.2000.03885.x"},{"key":"2023110105251434000_50.Suppl_2.4.5","doi-asserted-by":"crossref","first-page":"3109","DOI":"10.4238\/2011.December.15.2","article-title":"Association between HLA-Cw*0602 polymorphism and psoriasis risk: A meta-analysis","volume":"10","author":"Wu","year":"2011","journal-title":"Genet Mol Res"},{"key":"2023110105251434000_50.Suppl_2.4.6","doi-asserted-by":"publisher","DOI":"10.1038\/sj.jid.5700118"},{"key":"2023110105251434000_50.Suppl_2.4.7","first-page":"248","article-title":"Guttate psoriasis following presumed coxsackievirus A","volume":"104","author":"Rychik","year":"2019","journal-title":"Cutis"},{"key":"2023110105251434000_50.Suppl_2.4.8","doi-asserted-by":"crossref","first-page":"e237367","DOI":"10.1136\/bcr-2020-237367","article-title":"Guttate psoriasis secondary to COVID-19","volume":"13","author":"Gananandan","year":"2020","journal-title":"BMJ Case Rep"},{"key":"2023110105251434000_50.Suppl_2.4.9","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1111\/bjd.18203","article-title":"Respiratory virus infection triggers acute psoriasis flares across different clinical subtypes and genetic backgrounds","volume":"181","author":"Sbidian","year":"2019","journal-title":"Br J Dermatol"},{"key":"2023110105251434000_50.Suppl_2.4.10","doi-asserted-by":"publisher","DOI":"10.1001\/archderm.1992.01680110049004"},{"key":"2023110105251434000_50.Suppl_2.4.11","doi-asserted-by":"publisher","DOI":"10.1001\/archderm.1996.03890300147032"},{"key":"2023110105251434000_50.Suppl_2.4.12","doi-asserted-by":"publisher","DOI":"10.1111\/j.0022-202X.2004.23501.x"},{"key":"2023110105251434000_50.Suppl_2.4.13","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2017.07.004"},{"key":"2023110105251434000_50.Suppl_2.4.14","doi-asserted-by":"publisher","DOI":"10.1016\/j.coi.2017.08.008"},{"key":"2023110105251434000_50.Suppl_2.4.15","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1016\/S0733-8635(18)30039-1","article-title":"Guttate and plaque psoriasis","volume":"13","author":"Christophers","year":"1995","journal-title":"Dermatol Clin"},{"key":"2023110105251434000_50.Suppl_2.4.16","doi-asserted-by":"crossref","first-page":"738","DOI":"10.5021\/ad.2015.27.6.738","article-title":"Tissue and serum inflammatory cytokine levels in Korean psoriasis patients: A comparison between plaque and guttate psoriasis","volume":"27","author":"Roh","year":"2015","journal-title":"Ann Dermatol"},{"key":"2023110105251434000_50.Suppl_2.4.17","doi-asserted-by":"crossref","first-page":"S179","DOI":"10.1016\/j.jid.2019.03.1114","article-title":"Convergent molecular and histologic profiles of guttate and plaque psoriasis [abstract]","volume":"139","author":"Hawkes","year":"2019","journal-title":"J Invest Dermatol"},{"key":"2023110105251434000_50.Suppl_2.4.18","doi-asserted-by":"crossref","first-page":"2530","DOI":"10.1038\/jid.2013.151","article-title":"CXCR4 negatively regulates keratinocyte proliferation in IL-23-mediated psoriasiform dermatitis","volume":"133","author":"Takekoshi","year":"2013","journal-title":"J Invest Dermatol"},{"key":"2023110105251434000_50.Suppl_2.4.19","first-page":"CD011541","article-title":"Non-antistreptococcal interventions for acute guttate psoriasis or an acute guttate flare of chronic psoriasis","volume":"4","author":"Maruani","year":"2019","journal-title":"Cochrane Database Syst Rev"},{"key":"2023110105251434000_50.Suppl_2.4.20","first-page":"CD011571","article-title":"Antistreptococcal interventions for guttate and chronic plaque psoriasis","volume":"3","author":"Dupire","year":"2019","journal-title":"Cochrane Database Syst Rev"},{"key":"2023110105251434000_50.Suppl_2.4.21","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1016\/j.jdcr.2017.06.015","article-title":"Ustekinumab-induced remission of recalcitrant guttate psoriasis: A case series","volume":"3","author":"Brummer","year":"2017","journal-title":"JAAD Case Rep"},{"key":"2023110105251434000_50.Suppl_2.4.22","first-page":"822","article-title":"Resolution of guttate psoriasis plaques after one-time administration of guselkumab","volume":"18","author":"Hall","year":"2019","journal-title":"J Drugs Dermatol"},{"key":"2023110105251434000_50.Suppl_2.4.23","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1111\/ijd.15478","article-title":"Durable remissions of guttate psoriasis following short courses of IL-17 inhibitors","volume":"60","author":"Printy","year":"2021","journal-title":"Int J Dermatol"},{"key":"2023110105251434000_50.Suppl_2.4.24","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1177\/2475530320970538","article-title":"Successful treatment of guttate psoriasis with ixekizumab: a case series","volume":"6","author":"Fogel","year":"2021","journal-title":"J Psoriasis Psoriatic Arthritis"},{"key":"2023110105251434000_50.Suppl_2.4.25","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.jdcr.2022.04.019","article-title":"A case series of early biologic therapy in guttate psoriasis: targeting resident memory T cell activity as a potential novel therapeutic modality","volume":"24","author":"Flora","year":"2022","journal-title":"JAAD Case Rep"},{"key":"2023110105251434000_50.Suppl_2.4.26","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1007\/BF00184491","article-title":"A double-blind, randomized, placebo-controlled trial of n-3 fatty acid based lipid infusion in acute, extended guttate psoriasis. Rapid improvement of clinical manifestations and changes in neutrophil leukotriene profile","volume":"71","author":"Grimminger","year":"1993","journal-title":"Clin Investig"}],"container-title":["The Journal of Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.3899\/jrheum.2023-0500","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T12:32:00Z","timestamp":1698841920000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.jrheum.org\/lookup\/doi\/10.3899\/jrheum.2023-0500"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9,1]]},"references-count":26,"journal-issue":{"issue":"Suppl 2","published-online":{"date-parts":[[2023,11,1]]},"published-print":{"date-parts":[[2023,11]]}},"alternative-id":["10.3899\/jrheum.2023-0500"],"URL":"https:\/\/doi.org\/10.3899\/jrheum.2023-0500","relation":{},"ISSN":["0315-162X","1499-2752"],"issn-type":[{"value":"0315-162X","type":"print"},{"value":"1499-2752","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,9,1]]}}}